Evolent Health, Inc. (FRA:9EH)

Market Cap	404.23M
Revenue (ttm)	1.75B
Net Income (ttm)	-154.17M
Shares Out	n/a
EPS (ttm)	-1.34
PE Ratio	n/a
Forward PE	17.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,678
Average Volume	293
Open	3.600
Previous Close	3.580
Day's Range	3.600 - 3.640
52-Week Range	3.120 - 12.200
Beta	n/a
RSI	32.54
Earnings Date	Feb 27, 2026

About Evolent Health

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workf...

• Industry: Prepackaged Software
• Founded: 2011
• Employees: 4,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 9EH

Financial Performance

In 2024, Evolent Health's revenue was $2.55 billion, an increase of 30.09% compared to the previous year's $1.96 billion. Losses were -$93.45 million, -34.31% less than in 2023.

Financial numbers in USD